Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-01-11
2005-01-11
Woitach, Joseph T. (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100, C536S023100
Reexamination Certificate
active
06841538
ABSTRACT:
The present invention relates to methods for increasing the efficiency of transformation of cycling cells, the methods comprising synchronizing cells at a first stage of the cell cycle, and transforming the cells at a second stage of the cell cycle within about one cell cycle of the first stage with a genetically engineered nucleic acid that encodes a desired gene product. The invention further relates to cancer therapy and, in particular, to methods of efficiently transforming cancer cells with nucleic acids that encode gene products that inhibit the growth of cancer cells.
REFERENCES:
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 5571797 (1996-11-01), Ohno et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5591601 (1997-01-01), Wagner et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5688773 (1997-11-01), Chiocca et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 5747469 (1998-05-01), Roth et al.
patent: 5888735 (1999-03-01), Vogelstein et al.
patent: 0 760 675 (1997-03-01), None
patent: 1548621 (1979-07-01), None
patent: WO 9207943 (1992-05-01), None
patent: WO 9400095 (1994-01-01), None
patent: WO 9508994 (1995-04-01), None
patent: WO 9640964 (1996-12-01), None
patent: WO 9641875 (1996-12-01), None
Bernhard et al. Radiat Environ Biophys 34:79-83 (1995).*
Hwang et al. Radiatio Research 150(Suppl.)S52-S59 (1998).*
Rieder et al. JCB 142(4):1013-1022 (Aug. 1998).*
Mikkelsen et al. Radiat Res 132(2) (Nov. 1992).*
Giancoli, PHYSICS Principles with Applications, Third Edition, p. 579.*
Serway, PHYSICS for Scitistts & Engineers, 2nd Edition, pp. 786-787.*
Son et al. Proceedings from the National Academy of Science 91:12669-12672, Dec. 1994.*
Spang-Thomsen et al. European Journal of Cancer and Clinical Oncology 20(6):849-855, 1984.*
Yorifuji et al. FEBS Letters 245(1-2):201-203, Mar. 1989.*
Cohen,Immunol. Today, 14(3):126-130 (1993).
Gavriel, et al.,J. Cell Biol., 119(3):493-501 (1992).
Lunardi-Iskandar, et al.,Clin. Exp. Immunol., 60:285-293 (1985).
Son, et al.,Proc. Natl. Acad. Sci. USA, 91:12669-12672 (1994).
White, et al.,J. Virol., 52(2):410-419 (1984).
Brigham, et al.,Am. J. Med. Sci., 298(4):278-281 (1989).
Cone, et al.,Proc. Natl. Acad. Sci. USA, 81:6349-6353 (1984).
Eglitis, et al.,BioTEchniques, 6(7):608-614 (1988).
Gilboa, et al.,BioTechniques, 4(6):504-512 (1986).
Hyde, et al,Nature, 362:250-256 (1993).
Ikegami, et al.,Nature, 275:458-460 (1978).
Keyomarsi, et al.,Cancer Research, 51:3602-3609 (1991).
Legendre, et al.,Pharmaceutical Research, 9(10):1235-1242 (1992).
Mann, et al.,Cell, 33:153-159 (1983).
Miller, et al.,BioTechniques, 7(9):981-990 (1989).
Peters,Nature, 371:204-205 (1994).
Sherr,Cell, 73:1059-1065 (1993).
Tseng, et al.,Biotechnology and Bioengineering, 50:548-554 (1996).
Wahl, et al.,Biochemistry, 25:7821-7827 (1986).
Zabner, et al.,J. Biol. Chem., 270(32):18997-19007 (1995).
Zhu, et al.,Science, 261:209-211 (1993).
Durand Ralph E.
Graham Roger W.
Joshi Phalgun B.
British Columbia Cancer Agency
Inex Pharmaceuticals Corporation
Townsend and Townsend / and Crew LLP
Woitach Joseph T.
LandOfFree
Combination therapy using nucleic acids and radio therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy using nucleic acids and radio therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using nucleic acids and radio therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3400228